findmyKOL
Clinical trialNCT05525182UnknownPhase 2/PHASE3Interventional

Efficacy and Safety of ES16001 in Patients With COVID-19

SponsorGenencell Co. Ltd.Enrollment706COVID-19
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Soon Chun Hyang University Hospital

    Bucheon-si, South Korea

    Ansoo Jang
    Recruiting
  • Eunpyeong, St.Mary'S Hospital

    Seoul, South Korea

    Sanghaak Lee
    Recruiting
  • Kyung Hee University Medical Center

    Seoul, South Korea

    Misuk Lee
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jul 2021
Primary completion
31 Dec 2023
Completion
31 Dec 2023
Last update posted
22 Feb 2023
Registered enrollment
706
Registry id
NCT05525182
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.